TY - JOUR AU - Fitzmaurice, C. AU - Dicker, D. AU - Pain, A. AU - Hamavid, H. AU - Moradi-Lakeh, M. AU - MacIntyre, M. F. PY - 2015 DA - 2015// TI - The global burden of cancer 2013 JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.0735 DO - 10.1001/jamaoncol.2015.0735 ID - Fitzmaurice2015 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. AU - Zhang, S. AU - Zeng, H. AU - Bray, F. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Rustgi, A. K. AU - El-Serag, H. B. PY - 2014 DA - 2014// TI - Esophageal carcinoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMra1314530 DO - 10.1056/NEJMra1314530 ID - Rustgi2014 ER - TY - STD TI - Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet (London, England). 2017;390(10110):2383–96. ID - ref4 ER - TY - JOUR AU - Pennathur, A. AU - Gibson, M. K. AU - Jobe, B. A. AU - Luketich, J. D. PY - 2013 DA - 2013// TI - Oesophageal carcinoma JO - Lancet (London, England) VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)60643-6 DO - 10.1016/S0140-6736(12)60643-6 ID - Pennathur2013 ER - TY - JOUR AU - Shapiro, J. AU - Lanschot, J. J. B. AU - Hulshof, M. AU - Hagen, P. AU - Berge Henegouwen, M. I. AU - Wijnhoven, B. P. L. PY - 2015 DA - 2015// TI - Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00040-6 DO - 10.1016/S1470-2045(15)00040-6 ID - Shapiro2015 ER - TY - JOUR AU - Mariette, C. AU - Robb, W. B. AU - Piessen, G. AU - Adenis, A. PY - 2015 DA - 2015// TI - Neoadjuvant chemoradiation in oesophageal cancer JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00127-8 DO - 10.1016/S1470-2045(15)00127-8 ID - Mariette2015 ER - TY - JOUR AU - Ohnuma, H. AU - Sato, Y. AU - Hayasaka, N. AU - Matsuno, T. AU - Fujita, C. AU - Sato, M. PY - 2018 DA - 2018// TI - Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: a phase II study JO - Cancer Sci VL - 109 UR - https://doi.org/10.1111/cas.13772 DO - 10.1111/cas.13772 ID - Ohnuma2018 ER - TY - JOUR AU - Sato, M. AU - Ando, N. PY - 2011 DA - 2011// TI - Neoadjuvant chemotherapy followed by surgery as standard treatment for stage II + III thoracic esophageal squamous cell carcinoma in Japan JO - Nihon Geka Gakkai zasshi VL - 112 ID - Sato2011 ER - TY - JOUR AU - Al-Batran, S. E. AU - Hofheinz, R. D. AU - Pauligk, C. AU - Kopp, H. G. AU - Haag, G. M. AU - Luley, K. B. PY - 2016 DA - 2016// TI - Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30531-9 DO - 10.1016/S1470-2045(16)30531-9 ID - Al-Batran2016 ER - TY - JOUR AU - Mandard, A. M. AU - Dalibard, F. AU - Mandard, J. C. AU - Marnay, J. AU - Henry-Amar, M. AU - Petiot, J. F. PY - 1994 DA - 1994// TI - Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations JO - Cancer VL - 73 UR - https://doi.org/3.0.CO;2-C DO - 3.0.CO;2-C ID - Mandard1994 ER - TY - JOUR AU - Karamitopoulou, E. AU - Thies, S. AU - Zlobec, I. AU - Ott, K. AU - Feith, M. AU - Slotta-Huspenina, J. PY - 2014 DA - 2014// TI - Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches JO - Am J Surg Pathol VL - 38 UR - https://doi.org/10.1097/PAS.0000000000000255 DO - 10.1097/PAS.0000000000000255 ID - Karamitopoulou2014 ER - TY - JOUR AU - Schmidt, T. AU - Sicic, L. AU - Blank, S. AU - Becker, K. AU - Weichert, W. AU - Bruckner, T. PY - 2014 DA - 2014// TI - Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2014.94 DO - 10.1038/bjc.2014.94 ID - Schmidt2014 ER - TY - JOUR AU - Langer, R. AU - Ott, K. AU - Feith, M. AU - Lordick, F. AU - Siewert, J. R. AU - Becker, K. PY - 2009 DA - 2009// TI - Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas JO - Modern Pathol VL - 22 UR - https://doi.org/10.1038/modpathol.2009.123 DO - 10.1038/modpathol.2009.123 ID - Langer2009 ER - TY - JOUR AU - Brucher, B. L. AU - Becker, K. AU - Lordick, F. AU - Fink, U. AU - Sarbia, M. AU - Stein, H. PY - 2006 DA - 2006// TI - The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21850 DO - 10.1002/cncr.21850 ID - Brucher2006 ER - TY - JOUR AU - Wu, T. T. AU - Chirieac, L. R. AU - Abraham, S. C. AU - Krasinskas, A. M. AU - Wang, H. AU - Rashid, A. PY - 2007 DA - 2007// TI - Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome JO - Am J Surg Pathol VL - 31 UR - https://doi.org/10.1097/01.pas.0000213312.36306.cc DO - 10.1097/01.pas.0000213312.36306.cc ID - Wu2007 ER - TY - JOUR AU - Meerten, E. AU - Muller, K. AU - Tilanus, H. W. AU - Siersema, P. D. AU - Eijkenboom, W. M. AU - Dekken, H. PY - 2006 DA - 2006// TI - Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study JO - Br J Cancer VL - 94 UR - https://doi.org/10.1038/sj.bjc.6603134 DO - 10.1038/sj.bjc.6603134 ID - Meerten2006 ER - TY - JOUR AU - Schneider, P. M. AU - Baldus, S. E. AU - Metzger, R. AU - Kocher, M. AU - Bongartz, R. AU - Bollschweiler, E. PY - 2005 DA - 2005// TI - Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification JO - Ann Surg VL - 242 UR - https://doi.org/10.1097/01.sla.0000186170.38348.7b DO - 10.1097/01.sla.0000186170.38348.7b ID - Schneider2005 ER - TY - JOUR AU - Becker, K. AU - Mueller, J. D. AU - Schulmacher, C. AU - Ott, K. AU - Fink, U. AU - Busch, R. PY - 2003 DA - 2003// TI - Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy JO - Cancer VL - 98 UR - https://doi.org/10.1002/cncr.11660 DO - 10.1002/cncr.11660 ID - Becker2003 ER - TY - STD TI - Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14(1):1–36. ID - ref20 ER - TY - STD TI - Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14(1):37–65. ID - ref21 ER - TY - JOUR AU - Tong, D. K. AU - Law, S. AU - Kwong, D. L. AU - Chan, K. W. AU - Lam, A. K. AU - Wong, K. H. PY - 2010 DA - 2010// TI - Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-0995-2 DO - 10.1245/s10434-010-0995-2 ID - Tong2010 ER - TY - JOUR AU - Hatogai, K. AU - Fujii, S. AU - Kojima, T. AU - Daiko, H. AU - Kadota, T. AU - Fujita, T. PY - 2016 DA - 2016// TI - Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery JO - J Surg Oncol VL - 113 UR - https://doi.org/10.1002/jso.24151 DO - 10.1002/jso.24151 ID - Hatogai2016 ER - TY - JOUR AU - Huang, J. AU - Song, Q. AU - Wang, H. AU - Wang, H. AU - Xu, C. AU - Wang, X. PY - 2018 DA - 2018// TI - Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma JO - Hum Pathol. VL - 80 UR - https://doi.org/10.1016/j.humpath.2018.06.009 DO - 10.1016/j.humpath.2018.06.009 ID - Huang2018 ER - TY - JOUR AU - Hagen, P. AU - Hulshof, M. C. AU - Lanschot, J. J. AU - Steyerberg, E. W. AU - Berge Henegouwen, M. I. AU - Wijnhoven, B. P. PY - 2012 DA - 2012// TI - Preoperative chemoradiotherapy for esophageal or junctional cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1112088 DO - 10.1056/NEJMoa1112088 ID - Hagen2012 ER - TY - JOUR AU - Muijs, C. AU - Smit, J. AU - Karrenbeld, A. AU - Beukema, J. AU - Mul, V. AU - Dam, G. PY - 2014 DA - 2014// TI - Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer JO - Int J Radiat Oncol Biol Phys VL - 88 UR - https://doi.org/10.1016/j.ijrobp.2013.11.009 DO - 10.1016/j.ijrobp.2013.11.009 ID - Muijs2014 ER - TY - JOUR AU - Holscher, A. H. AU - Bollschweiler, E. AU - Bogoevski, D. AU - Schmidt, H. AU - Semrau, R. AU - Izbicki, J. R. PY - 2014 DA - 2014// TI - Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - a propensity score matched analysis JO - Eur J Cancer (Oxford. England : 1990) VL - 50 UR - https://doi.org/10.1016/j.ejca.2014.08.020 DO - 10.1016/j.ejca.2014.08.020 ID - Holscher2014 ER - TY - JOUR AU - Stahl, M. AU - Walz, M. K. AU - Stuschke, M. AU - Lehmann, N. AU - Meyer, H. J. AU - Riera-Knorrenschild, J. PY - 2009 DA - 2009// TI - Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.0506 DO - 10.1200/JCO.2008.17.0506 ID - Stahl2009 ER - TY - JOUR AU - Hermann, R. M. AU - Horstmann, O. AU - Haller, F. AU - Perske, C. AU - Christiansen, H. AU - Hille, A. PY - 2006 DA - 2006// TI - Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? JO - Dis Esophagus VL - 19 UR - https://doi.org/10.1111/j.1442-2050.2006.00589.x DO - 10.1111/j.1442-2050.2006.00589.x ID - Hermann2006 ER - TY - JOUR AU - Okumura, H. AU - Uchikado, Y. AU - Matsumoto, M. AU - Owaki, T. AU - Kita, Y. AU - Omoto, I. PY - 2013 DA - 2013// TI - Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy JO - Int J Clin Oncol VL - 18 UR - https://doi.org/10.1007/s10147-012-0383-y DO - 10.1007/s10147-012-0383-y ID - Okumura2013 ER - TY - JOUR AU - Holscher, A. H. AU - Drebber, U. AU - Schmidt, H. AU - Bollschweiler, E. PY - 2014 DA - 2014// TI - Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma JO - Ann Surg VL - 260 UR - https://doi.org/10.1097/SLA.0000000000000964 DO - 10.1097/SLA.0000000000000964 ID - Holscher2014 ER - TY - JOUR AU - Chirieac, L. R. AU - Swisher, S. G. AU - Ajani, J. A. AU - Komaki, R. R. AU - Correa, A. M. AU - Morris, J. S. PY - 2005 DA - 2005// TI - Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20916 DO - 10.1002/cncr.20916 ID - Chirieac2005 ER - TY - JOUR AU - Chao, Y. K. AU - Chuang, W. Y. AU - Chang, H. K. AU - Tseng, C. K. AU - Yeh, C. J. AU - Liu, Y. H. PY - 2017 DA - 2017// TI - Prognosis of patients with esophageal squamous cell carcinoma who achieve major histopathological response after neoadjuvant chemoradiotherapy JO - Eur J Surg Oncol VL - 43 UR - https://doi.org/10.1016/j.ejso.2016.05.036 DO - 10.1016/j.ejso.2016.05.036 ID - Chao2017 ER - TY - JOUR AU - Francis, A. M. AU - Sepesi, B. AU - Correa, A. M. AU - Blum, M. A. AU - Erasmus, J. J. AU - Lee, J. H. PY - 2013 DA - 2013// TI - The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma JO - Ann Surg VL - 258 UR - https://doi.org/10.1097/SLA.0b013e3182a196f4 DO - 10.1097/SLA.0b013e3182a196f4 ID - Francis2013 ER - TY - JOUR AU - Noble, F. AU - Nolan, L. AU - Bateman, A. C. AU - Byrne, J. P. AU - Kelly, J. J. AU - Bailey, I. S. PY - 2013 DA - 2013// TI - Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus JO - World J Gastroenterol VL - 19 UR - https://doi.org/10.3748/wjg.v19.i48.9282 DO - 10.3748/wjg.v19.i48.9282 ID - Noble2013 ER - TY - JOUR AU - Thomas, M. AU - Rube, C. AU - Semik, M. AU - Eiff, M. AU - Freitag, L. AU - Macha, H. N. PY - 1999 DA - 1999// TI - Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.4.1185 DO - 10.1200/JCO.1999.17.4.1185 ID - Thomas1999 ER - TY - JOUR AU - Ruo, L. AU - Tickoo, S. AU - Klimstra, D. S. AU - Minsky, B. D. AU - Saltz, L. AU - Mazumdar, M. PY - 2002 DA - 2002// TI - Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy JO - Ann Surg VL - 236 UR - https://doi.org/10.1097/00000658-200207000-00012 DO - 10.1097/00000658-200207000-00012 ID - Ruo2002 ER - TY - JOUR AU - Akutsu, Y. AU - Shuto, K. AU - Kono, T. AU - Uesato, M. AU - Hoshino, I. AU - Shiratori, T. PY - 2012 DA - 2012// TI - The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma JO - J Surg Oncol VL - 105 UR - https://doi.org/10.1002/jso.23007 DO - 10.1002/jso.23007 ID - Akutsu2012 ER -